Thorsten Waloschek: Addressing Risks in Pregnancies with Sclerosis
Thorsten Waloschek, CEO of NeoPredics AG, shared a post on LinkedIn:
“A new study from The Lancet Rheumatology caught my attention this week.
It examines pregnancy outcomes in women with systemic sclerosis and highlights a reality we still need to confront. Even with a high live birth rate, the risks for mothers remain significantly elevated, particularly when it comes to preeclampsia, placental insufficiency, preterm birth, and severe postpartum complications.
Pregnancy places an extraordinary cardiovascular demand on the body, and for women with underlying autoimmune or vascular conditions, those risks can rise sharply. What concerns me most is that nearly 40 percent of pregnancies in the study showed worsening disease during pregnancy or within the first year postpartum. It reinforces something many in maternal health already know: we still lack effective, accessible tools for early risk detection.”
Read more.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 9, 2026, 15:36How Do GLP1 Drugs Impact Egg Quality? – Noor Sciences
-
Aug 9, 2026, 15:19Aleesha Grier: Something Powerful Happens When We Bring Assisted Reproductive Healthcare Into the Light
-
Aug 9, 2026, 15:00Kiani Davis: Providing Information Isn’t Necessarily the Same As Providing Education
-
Aug 9, 2026, 13:525 Evidence-Based Reasons Not to “Just Keep Trying” – Fertility Plus
-
Aug 9, 2026, 13:34The Future of Embryology Depends on How We Train the Next Generation – ASRM
-
Aug 9, 2026, 13:22Ritik Shukla: Menopause Is Not the End of Vitality – It’s the Beginning of a New Chapter
-
Aug 9, 2026, 12:57Szabó Gábor: 2 Imaging Modalities for Detecting Endometriosis
-
Aug 9, 2026, 12:36Shehab Gamal: Your Fertility Might Be Sitting in Your Fridge
-
Aug 9, 2026, 12:14Why Language Shapes PMOS Care – PCOS Awareness Association